Unraveling the Mysteries of Acute Flaccid Myelitis: Scientific Opportunities and Priorities for Future Research

Clin Infect Dis. 2021 Jun 1;72(11):2044-2048. doi: 10.1093/cid/ciaa1432.

Abstract

Since 2014, cases of acute flaccid myelitis (AFM) have been reported in the United States in increasing numbers biennially, occurring in the late summer and early fall. Although there is unlikely to be a single causative agent of this syndrome, non-polio enteroviruses, including enterovirus D-68 (EV-D68), have had epidemiological and laboratory associations with AFM. Much remains to be known about AFM and AFM-associated enteroviruses, including disease pathogenesis and the best strategies for development of therapeutics or preventive modalities including vaccines. To catalyze research that addresses these scientific and clinical gaps, the National Institute of Allergy and Infectious Diseases convened a workshop entitled "AFM Preparedness: Addressing EV-D68 and Other AFM-Associated Enteroviruses" on 19-20 February 2020.

Keywords: acute flaccid myelitis; enterovirus D-68; enteroviruses.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Central Nervous System Viral Diseases*
  • Enterovirus D, Human*
  • Humans
  • Myelitis*
  • Neuromuscular Diseases*
  • United States

Supplementary concepts

  • acute flaccid myelitis